Navigation Links
Poniard Completes Patient Enrollment Target in Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer
Date:3/25/2009

, chief medical officer of Poniard. "The data from this trial is event-driven and we expect that the overall survival data from the SPEAR trial will show a significant survival advantage compared to patients who receive best supportive care alone. We believe this is the first important step to provide a new treatment option for the many SCLC patients who do not achieve clinical benefit from current first-line therapies. This would be a significant accomplishment for this aggressive tumor type that has very few FDA-approved drugs."

SPEAR Trial Design

The international, multi-center, randomized, controlled, pivotal Phase 3 SPEAR trial compares picoplatin plus best supportive care, to best supportive care alone, to evaluate the efficacy and safety of picoplatin after relapse. Best supportive care includes care and treatment to optimize the comfort of patients and their ability to function, as well as to minimize the side effects of palliative cancer treatments. The primary efficacy endpoint is overall survival. Overall response rates, progression-free survival and disease control are also being evaluated.

The SPEAR trial is being conducted under the review of an independent Data Monitoring Committee, which assesses use of best supportive care to ensure balance in both arms of the trial, as well as the use of picoplatin and its safety in the treatment arm. The trial is also being conducted under a Special Protocol Assessment (SPA) developed with the FDA.

Poniard has received Orphan Drug and Fast Track designations for picoplatin for the second-line treatment of refractory or resistant SCLC from the FDA, and Orphan Drug designation from the European Commission for medicinal product status for SCLC.

About Picoplatin

Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors. Study data to date indicate that it has an improved saf
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  The Partnership to Fight Chronic Disease ... health care leaders and a new study analyzing the impact ... PFCD is a nationwide coalition working to educate policy makers and ... at the Capitol was focused on how the Iowa ...
(Date:1/23/2015)... ATLANTA , Jan. 23, 2015 More than a ... a quarter of those with private insurance, filled a prescription ... to a report in this week,s Morbidity and Mortality Weekly ... health care providers to treat moderate to severe pain.  They ...
(Date:1/23/2015)... Fla. , Jan. 23, 2015  HyGreen, Inc., a ... agreement and partnership with RCA Medical, a subsidiary of ... . Each year, hundreds of millions ... care-associated infections as organisms are transmitted from patient to ...
Breaking Medicine Technology:New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3HyGreen Partners with RCA Medical in Johannesburg, South Africa 2
... Medical, Inc. (OTC Bulletin Board: AEMD ), the ... and cancer, announced today that its Chairman and Chief Executive ... Annual Global Investment Conference at 3:40 p.m. EDT on September ... York Palace Hotel in New York City from September 12-15, ...
... (Nasdaq: BNVI, BNVID) announced today that it will effect a ... opening of trading on August 31, 2010. The primary objective ... to better enable the company to maintain the listing of ... common stock will continue trading on The NASDAQ Capital Market ...
Cached Medicine Technology:Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference 2Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference 3Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference 4Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference 5Bionovo Announces Reverse Stock Split 2Bionovo Announces Reverse Stock Split 3
(Date:1/22/2015)... 2015 Deer Path of Huntley -- ... Day Happy Hour from 3 p.m. to 4 p.m. on Feb. ... in Huntley, Illinois, serves adults with physical disabilities between the ages ... Valentine's Day treats, games and sweetheart-themed karaoke. , For more information ...
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort located ... the number one best large hotel for families in the ... their annual Travelers’ Choice Awards. , TripAdvisor represents the ... home to millions of unbiased and honest traveler reviews. The ...
(Date:1/22/2015)... is a famous wedding dress company offering many trendy designs. ... Facebook, Twitter, and Pinterest. The fans will have an opportunity ... every week. , Moreover, the company has extended its 2015 ... homepage for more information. , Angelweddingdress is a ...
(Date:1/22/2015)... 22, 2015 A new white paper ... and person-centeredness in the long-term care environment as well ... the continuum. The paper, “The Power of Person-Centeredness in ... and practices of the patient, resident and family experience ...
(Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved television host, ... 32nd Annual Miami Breast Cancer Conference planned and ... , shares that “a fast-growing, virulent” cancer in her ... not followed up her clean mammogram with an ultrasound. ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... , MIAMI, Dec. 22 ... is CA123 , an aggregator of the latest news and ... professionals. CA123 links to its home site through either ... to podcasts, blogs to clinical trial information, CA123 is a one-stop ...
... found out he would be the first patient in North ... UT Southwestern Medical Center, he wasn,t nervous at all. ... excited about it," Mr. Harrison said. "I had a rare ... associate professor of cardiovascular and thoracic surgery at UT Southwestern, ...
... mutation that affected Queen Victoria and her European relatives, scientific ... trace rare genetic disease mutations, the tool can turn a ... Tel Aviv University has its own deep sequencer one ... in a new Genome Facility. The tool will add ...
... , PINELLAS PARK, Fla., Dec. 22 ... better themselves by making a New Year,s,resolution list. Many will ... proper diet and regular visits to healthcare,professionals. One aspect of ... It,s important for Hispanics to include a,comprehensive eye exam on their ...
... , PHILADELPHIA, Dec. 22 A landmark autism ... inherited blindness, both at The Children,s Hospital of Philadelphia, were ... three national publications: Time magazine, Discover ... "Our researchers and physicians are pushing the boundaries of biomedical ...
... genetics of cancers from different parts of the body may ... That process is already gaining traction at the University of ... are one year into a three-year project to collect and ... by 1,000 tumors. Over the past year, working ...
Cached Medicine News:Health News:New iPhone App Provides New Services for Cancer Patients 2Health News:Fort Worth patient first in North Texas to undergo robot-assisted surgery for removal of lung tumor 2Health News:Adding a genetic supertool 2Health News:Focus on Healthy Sight for the New Year 2Health News:Focus on Healthy Sight for the New Year 3Health News:Gene Findings in Autism, Blindness at Children's Hospital Top National Lists of Medical Advances in 2009 2Health News:Gene Findings in Autism, Blindness at Children's Hospital Top National Lists of Medical Advances in 2009 3Health News:Chicago Cancer Genome Project studies genetics of 1,000 tumors 2Health News:Chicago Cancer Genome Project studies genetics of 1,000 tumors 3Health News:Chicago Cancer Genome Project studies genetics of 1,000 tumors 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: